Chitinase-3 like-protein-1 function and its role in diseases

T Zhao, Z Su, Y Li, X Zhang, Q You - Signal transduction and targeted …, 2020 - nature.com
Abstract Non-enzymatic chitinase-3 like-protein-1 (CHI3L1) belongs to glycoside hydrolase
family 18. It binds to chitin, heparin, and hyaluronic acid, and is regulated by extracellular …

Tumor-associated macrophages in human breast, colorectal, lung, ovarian and prostate cancers

I Larionova, G Tuguzbaeva, A Ponomaryova… - Frontiers in …, 2020 - frontiersin.org
Tumor-associated macrophages (TAMs) are major innate immune cells that constitute up to
50% of the cell mass of human tumors. TAMs are highly heterogeneous cells that originate …

Using biochemical markers of bone turnover in clinical practice.

FR Singer, DR Eyre - Cleveland Clinic journal of medicine, 2008 - europepmc.org
Biochemical markers of bone turnover provide clinically useful evidence of the normal and
pathologic processes that reflect bone cell activity in the skeleton. Understanding the …

Role of chitinase-like proteins in cancer

J Kzhyshkowska, S Yin, T Liu, V Riabov… - Biological …, 2016 - degruyter.com
Chitinase-like proteins (CLPs) are lectins combining properties of cytokines and growth
factors. Human CLPs include YKL-40, YKL-39 and SI-CLP that are secreted by cancer cells …

Plasma YKL-40: a potential new cancer biomarker?

JS Johansen, NA Schultz, BV Jensen - Future Oncology, 2009 - Taylor & Francis
YKL-40, a 40-kDa secreted glycoprotein, with its gene located on chromosome 1q32. 1, is
produced by cancer cells and inflammatory cells and has a role in inflammation, cell …

A phase III extension trial with a 1-arm crossover from leuprolide to degarelix: comparison of gonadotropin-releasing hormone agonist and antagonist effect on …

ED Crawford, B Tombal, K Miller, L Boccon-Gibod… - The Journal of …, 2011 - Elsevier
PURPOSE: We investigated the efficacy and safety of degarelix treatment and the effects of
switching from leuprolide to degarelix in an ongoing extension study with a median 27.5 …

Circulating glioma biomarkers

JM Kros, DM Mustafa, LJM Dekker… - Neuro …, 2015 - academic.oup.com
Validated biomarkers for patients suffering from gliomas are urgently needed for
standardizing measurements of the effects of treatment in daily clinical practice and trials …

Upregulation of YKL-40 promotes metastatic phenotype and correlates with poor prognosis and therapy response in patients with colorectal cancer

M De Robertis, MR Greco, RA Cardone, T Mazza… - Cells, 2022 - mdpi.com
YKL-40 is a heparin-and chitin-binding glycoprotein that belongs to the family of glycosyl
hydrolases but lacks enzymatic properties. It affects different (patho) physiological …

Androgen deprivation therapy: past, present and future

F Schröder, ED Crawford, K Axcrona, H Payne… - BJU …, 2012 - Wiley Online Library
Since Huggins and Hodges demonstrated the responsiveness of prostate cancer to
androgen deprivation therapy (ADT), androgen‐suppressing strategies have formed the …

CHI3L1 (YKL‐40) is expressed in human gliomas and regulates the invasion, growth and survival of glioma cells

BM Ku, YK Lee, J Ryu, JY Jeong, J Choi… - … journal of cancer, 2011 - Wiley Online Library
Abstract Chitinase 3‐like 1 (CHI3L1) is a secreted glycoprotein that has pleiotropic activity in
aggressive cancers. In our study, we examined the expression and function of CHI3L1 in …